STOCK TITAN
  1. Home
  2. Sec-filings
  3. RBOT
  4. [8-K] Vicarious Surgical Inc. Reports Material Event

RBOT Files 8-K; Exhibit 99.1 Contains Q2 Results and Business Update

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Vicarious Surgical Inc. furnished a Current Report announcing that it issued a press release with its results for the second quarter ended June 30, 2025 and providing a business update. The 8-K attaches that press release as Exhibit 99.1 and includes an Inline XBRL cover page file as Exhibit 104. The filing states the furnished materials are not "filed" for purposes of the Exchange Act and are not incorporated by reference elsewhere unless explicitly stated. The report does not include financial tables, numerical earnings or balance sheet figures within the filing itself; readers must consult the attached press release for detailed results.

Positive

  • None.

Negative

  • None.

Insights

TL;DR The company furnished a press release with its Q2 2025 results and a business update; the release is furnished, not filed.

The 8-K notifies investors that Q2 results and a business update were released and makes the press release available as Exhibit 99.1. The filing itself contains no financial statements or numeric results, and explicitly states the furnished material is not subject to Section 18 liabilities. For analysts, this is a routine disclosure step that directs stakeholders to the press release for substantive financial details.

TL;DR Routine 8-K furnishing a press release; procedural disclosure with limited governance implications.

The report documents the company’s communication of quarterly results via an attached press release and includes the Inline XBRL cover page. The filing language clarifies the exhibit is "furnished" rather than "filed," which limits legal exposure under Section 18. There are no governance actions, officer changes, or material transactions disclosed in this form.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Understanding 8-K Material Events →
false 0001812173 0001812173 2025-08-12 2025-08-12 0001812173 RBOT:ClassCommonStockParValue0.0001PerShareMember 2025-08-12 2025-08-12 0001812173 RBOT:WarrantsToPurchaseOneShareOfClassCommonStockEachAtExercisePriceOf11.50PerShareMember 2025-08-12 2025-08-12 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 12, 2025

 

 

 

VICARIOUS SURGICAL INC.

(Exact name of registrant as specified in its charter)

 

 

 

 

Delaware   001-39384   87-2678169
(State or other jurisdiction
of incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

78 Fourth Avenue    
Waltham, Massachusetts   02451
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (617) 868-1700

 

N/A

(Former name or former address, if changed since last report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on
which registered
Class A common stock, par value $0.0001 per share   RBOT   The New York Stock Exchange
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share   RBOT WS   The New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 2.02. Results of Operations and Financial Condition.

 

On August 12, 2025, Vicarious Surgical Inc. (the “Company”) issued a press release announcing its results for the second quarter ended June 30, 2025 and providing a business update.

  

A copy of the press release issued on August 12, 2025 is furnished as Exhibit 99.1 hereto.

 

The information in this Current Report on Form 8-K (including Exhibit 99.1) shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated August 12, 2025
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VICARIOUS SURGICAL INC.
     
  By: /s/ Stephen From
  Name:  Stephen From
  Title: Chief Executive Officer

 

Date: August 12, 2025

  

2

 

 

Source: View Original Filing on SEC EDGAR

FAQ

What did Vicarious Surgical (RBOT) disclose in this Form 8-K?

The company furnished a press release announcing its results for the second quarter ended June 30, 2025 and provided a business update; the press release is attached as Exhibit 99.1.

Is the press release in the 8-K considered "filed" under the Exchange Act?

No. The 8-K explicitly states that the information, including Exhibit 99.1, is furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Exchange Act.

Does the 8-K include the company’s financial statements or detailed earnings figures?

No. The filing does not include financial tables or numeric earnings data; it furnishes a press release for the detailed results.

Where can I find the press release referenced in the 8-K for RBOT?

The press release is included as Exhibit 99.1 to the Current Report on Form 8-K.

Which securities of Vicarious Surgical are listed in the 8-K?

The filing lists Class A common stock (RBOT) and warrants (RBOT WS), both registered on the New York Stock Exchange.